NEVRLKA, Jiří, Katarína DÍTĚTOVÁ, Lenka ZDRAŽILOVÁ DUBSKÁ and Zlatica NEVRLKOVÁ. Allergen-specific immunotherapy in adults with birch pollen-related asthma: real life evidence. In 2023 ERS International Congress. 2023. ISSN 0903-1936. Available from: https://dx.doi.org/10.1183/13993003.congress-2023.PA4751.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Allergen-specific immunotherapy in adults with birch pollen-related asthma: real life evidence.
Name in Czech Alergenová imunoterapie u dospělých s astmatem ve vazbě na pyl břízy: data z klinické praxe
Authors NEVRLKA, Jiří (203 Czech Republic, guarantor, belonging to the institution), Katarína DÍTĚTOVÁ (703 Slovakia, belonging to the institution), Lenka ZDRAŽILOVÁ DUBSKÁ (203 Czech Republic, belonging to the institution) and Zlatica NEVRLKOVÁ (703 Slovakia).
Edition 2023 ERS International Congress, 2023.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30102 Immunology
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 24.300 in 2022
RIV identification code RIV/00216224:14110/23:00133268
Organization unit Faculty of Medicine
ISSN 0903-1936
Doi http://dx.doi.org/10.1183/13993003.congress-2023.PA4751
UT WoS 001109120508222
Keywords (in Czech) alergická rýma;průduškové astma;pyl břízy;imunoterapie
Keywords in English allergic rhinitis;bronchial asthma;birch pollen;immunotherapy
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 5/4/2024 09:20.
Abstract
Allergen-specific immunotherapy in adults with birch pollen-related asthma: real life evidence. - conference abstract.
Links
MUNI/A/1342/2022, interní kód MUName: Preklinický a klinický výzkum v oblasti farmakokinetiky, neuropsychofarmakologie a personalizované farmakoterapie v onkologii
Investor: Masaryk University, Preclinical and clinical research in pharmacokinetics, neuropsychopharmacology and personalized pharmacotherapy in oncology
90249, large research infrastructuresName: CZECRIN IV
PrintDisplayed: 30/9/2024 22:09